Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Oct-22 4:15 PM View:  | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 346,300 | -- | -- | (100%) 346.3K to 0 | |
| 06-Oct-22 4:20 PM View: | Graham Dawn Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 5,376 | -- | -- | (100%) 5.38K to 0 | |
| 06-Oct-22 4:15 PM View: | Choi Jung See Remarks | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 226,672 | -- | -- | (90%) 251.67K to 25.0K | |
| 06-Oct-22 4:15 PM View: | Smith-Whitley Kim See Remarks | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 5,980 | -- | -- | (100%) 5.98K to 0 | |
| 06-Oct-22 4:20 PM View: | Patrick Deval L Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 9,037 | -- | -- | (100%) 9.04K to 0 | |
| 06-Oct-22 4:20 PM View: | Yarno Wendy L Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 11,437 | -- | -- | (100%) 11.44K to 0 | |
| 06-Oct-22 4:15 PM View: | Choi Jung See Remarks | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 25,000 | -- | -- | (100%) 25.0K to 0 | |
| 06-Oct-22 4:21 PM View: | Perry Mark L Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 37,865 | -- | -- | (100%) 37.87K to 0 | |
| 06-Oct-22 4:20 PM View: | Thompson Alexis A. Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 3,308 | -- | -- | (100%) 3.31K to 0 | |
| 06-Oct-22 4:20 PM View: | Pizzo Philip A. Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 9,112 | -- | -- | (100%) 9.11K to 0 | |
| 06-Oct-22 4:20 PM View: | Morrison Scott W Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 6,637 | -- | -- | (100%) 6.64K to 0 | |
| 06-Oct-22 4:15 PM View: | Johnson David Lee Chief Commercial Officer | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 34,384 | -- | -- | (100%) 34.38K to 0 | |
| 06-Oct-22 4:15 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 39,680 | -- | -- | (100%) 39.68K to 0 | |
| 06-Oct-22 4:15 PM View: | Suvari Tricia Borga Chief Legal Officer | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 43,077 | -- | -- | (100%) 43.08K to 0 | |
| 06-Oct-22 4:20 PM View: | Pierce Glenn Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 26,437 | -- | -- | (100%) 26.44K to 0 | |
| 06-Oct-22 4:15 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 576,318 | -- | -- | (62%) 922.62K to 346.3K | |
| 06-Oct-22 4:15 PM View: | Farrow Jeffrey S Chief Financial Officer | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 26,739 | -- | -- | (100%) 26.74K to 0 | |
| 06-Oct-22 4:15 PM View: | Krehlik Carrie Chief Human Resources Officer | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 6,716 | -- | -- | (100%) 6.72K to 0 | |
| 04-Oct-22 5:00 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Oct-22 | Option Exercise | 1,557 | -- | -- | 4% 38.12K to 39.68K | |
| 29-Sep-22 8:43 PM View: | Choi Jung See Remarks | Global Blood Therapeutics, ... (GBT) | 29-Sep-22 | Gift | 73,855 | -- | -- | (23%) 325.53K to 251.67K | |
| 04-Oct-22 5:00 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 29-Sep-22 | Gift | 3,500 | -- | -- | (8%) 41.62K to 38.12K | |
| 06-Oct-22 4:15 PM View: | Johnson David Lee Chief Commercial Officer | Global Blood Therapeutics, ... (GBT) | 28-Sep-22 | Gift | 22,000 | -- | -- | (39%) 56.38K to 34.38K | |
| 29-Sep-22 8:48 PM View: | Farrow Jeffrey S Chief Financial Officer | Global Blood Therapeutics, ... (GBT) | 27-Sep-22 | Option Exercise | 23,653 | $16.40 | $387,909.00 | 766% 3.09K to 26.74K | |
| 29-Sep-22 8:43 PM View: | Choi Jung See Remarks | Global Blood Therapeutics, ... (GBT) | 27-Sep-22 | Option Exercise | 99,489 | $7.04 | $699,994.00 | 44% 226.04K to 325.53K | |
| 29-Sep-22 8:47 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 27-Sep-22 | Option Exercise | 29,755 | $19.17 | $570,391.00 | 251% 11.87K to 41.62K | |
| 29-Sep-22 8:45 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 27-Sep-22 | Option Exercise | 18,291 | $16.40 | $299,972.00 | 2% 901.83K to 920.12K | |
| 29-Sep-22 8:45 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 13-Sep-22 | Gift | 35,300 | -- | -- | 4% 901.83K to 937.13K | |
| 29-Sep-22 8:45 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 13-Sep-22 | Gift | 35,300 | -- | -- | (4%) 937.13K to 901.83K | |
| 29-Sep-22 8:45 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 09-Sep-22 | Gift | 221,200 | -- | -- | (20%) 1.12M to 901.83K | |
| 06-Sep-22 7:00 PM View: | Suvari Tricia Borga Chief Legal Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 4,971 | -- | -- | 12% 39.99K to 44.96K | |
| 06-Sep-22 7:00 PM View: | Choi Jung See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 1,861 | $68.15 | $126,827.00 | (< 1%) 227.9K to 226.04K | |
| 06-Sep-22 7:00 PM View: | Farrow Jeffrey S Chief Financial Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 4,971 | -- | -- | 16% 31.44K to 36.41K | |
| 06-Sep-22 7:00 PM View: | Choi Jung See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 4,971 | -- | -- | 2% 222.93K to 227.9K | |
| 06-Sep-22 7:00 PM View: | Farrow Jeffrey S Chief Financial Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Sale | 26,470 | $68.00 | $1,799,960.00 | (90%) 29.56K to 3.09K | |
| 06-Sep-22 7:00 PM View: | Krehlik Carrie Chief Human Resources Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 3,552 | $68.15 | $242,069.00 | (35%) 10.27K to 6.72K | |
| 06-Sep-22 7:00 PM View: | Johnson David Lee Chief Commercial Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 2,103 | $68.15 | $143,319.00 | (4%) 58.49K to 56.38K | |
| 06-Sep-22 7:00 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 1,342 | $68.15 | $91,457.30 | (10%) 13.21K to 11.87K | |
| 06-Sep-22 7:00 PM View: | Suvari Tricia Borga Chief Legal Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 1,881 | $68.15 | $128,190.00 | (4%) 44.96K to 43.08K | |
| 06-Sep-22 7:00 PM View: | Johnson David Lee Chief Commercial Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 4,971 | -- | -- | 9% 53.52K to 58.49K | |
| 06-Sep-22 7:00 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 3,878 | -- | -- | 42% 9.33K to 13.21K | |
| 06-Sep-22 7:00 PM View: | Farrow Jeffrey S Chief Financial Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 1,885 | $68.15 | $128,463.00 | (5%) 36.41K to 34.53K | |
| 06-Sep-22 7:00 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 18,553 | -- | -- | 2% 1.11M to 1.13M | |
| 06-Sep-22 7:00 PM View: | Smith-Whitley Kim See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 2,208 | -- | -- | 50% 4.38K to 6.59K | |
| 06-Sep-22 7:00 PM View: | Krehlik Carrie Chief Human Resources Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 10,268 | -- | -- | 100% 0 to 10.27K | |
| 06-Sep-22 7:00 PM View: | Love Ted W President and CEO Director | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 9,200 | $68.15 | $626,980.00 | (< 1%) 1.13M to 1.12M | |
| 06-Sep-22 7:00 PM View: | Farrow Jeffrey S Chief Financial Officer | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Sale | 4,971 | $68.00 | $338,028.00 | (14%) 34.53K to 29.56K | |
| 06-Sep-22 7:00 PM View: | Smith-Whitley Kim See Remarks | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 607 | $68.15 | $41,367.10 | (9%) 6.59K to 5.98K | |
| 06-Sep-22 7:00 PM View: | Johnson David Lee Chief Commercial Officer | Global Blood Therapeutics, ... (GBT) | 31-Aug-22 | Grant | 365 | $25.37 | $9,260.05 | < 1% 53.15K to 53.52K | |
| 06-Sep-22 7:00 PM View: | Habibizad Nazila See Remarks | Global Blood Therapeutics, ... (GBT) | 31-Aug-22 | Grant | 414 | $25.37 | $10,503.20 | 5% 8.92K to 9.33K | |
| 06-Sep-22 7:00 PM View: | Suvari Tricia Borga Chief Legal Officer | Global Blood Therapeutics, ... (GBT) | 31-Aug-22 | Grant | 385 | $25.37 | $9,767.45 | < 1% 39.6K to 39.99K |
